Stay updated on Glesatinib Combo With Nivolumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s displayed site revision changes from v3.8.0 to v3.8.1; the study record content remains unchanged.
    Difference
    0.0%
    Check dated 2026-11-18T02:50:57.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for this Phase 2 lung cancer study is available, with details about its design, participating locations, results, and study documents. It states that the study was terminated due to sponsor portfolio reprioritization and is no longer recruiting.
    Difference
    64%
    Check dated 2026-11-11T01:51:23.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-04T00:13:02.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A notice was added about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:18:02.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:23:23.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record with a standard error page. The additions reflect the 403 message, basic HTML boilerplate, and a Home link in the header/footer.
    Difference
    19%
    Check dated 2026-09-23T00:26:18.000Z thumbnail image

Stay in the know with updates to Glesatinib Combo With Nivolumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.